124 related articles for article (PubMed ID: 7591025)
1. Attenuation of genetic hypertension after short-term vasopressin V1A receptor antagonism.
Burrell LM; Phillips PA; Risvanis J; Aldred KL; Hutchins AM; Johnston CI
Hypertension; 1995 Nov; 26(5):828-34. PubMed ID: 7591025
[TBL] [Abstract][Full Text] [Related]
2. Modulation of genetic hypertension by short-term AVP V1A or V2 receptor antagonism in young SHR.
Naitoh M; Burrell LM; Risvanis J; Aldred KL; Rockell MD; Johnston CI; Phillips PA
Am J Physiol; 1997 Feb; 272(2 Pt 2):F229-34. PubMed ID: 9124400
[TBL] [Abstract][Full Text] [Related]
3. OPC-21268, a vasopressin V1 antagonist, produces hypotension in spontaneously hypertensive rats.
Yamada Y; Yamamura Y; Chihara T; Onogawa T; Nakamura S; Yamashita T; Mori T; Tominaga M; Yabuuchi Y
Hypertension; 1994 Feb; 23(2):200-4. PubMed ID: 8307629
[TBL] [Abstract][Full Text] [Related]
4. Resetting blood pressure in spontaneously hypertensive rats. The role of bradykinin.
O'Sullivan JB; Harrap SB
Hypertension; 1995 Feb; 25(2):162-5. PubMed ID: 7843764
[TBL] [Abstract][Full Text] [Related]
5. Influence of age and dietary sodium on the cardiovascular and renal effects of ramipril in spontaneously hypertensive rats.
Teräväinen TL; Mervaala EM; Pörsti I; Laakso J; Vapaatalo H; Karppanen H
Methods Find Exp Clin Pharmacol; 1997 Jun; 19(5):311-21. PubMed ID: 9379779
[TBL] [Abstract][Full Text] [Related]
6. Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats : effects of angiotensin receptor antagonism and converting enzyme inhibition.
Intengan HD; Thibault G; Li JS; Schiffrin EL
Circulation; 1999 Nov; 100(22):2267-75. PubMed ID: 10578002
[TBL] [Abstract][Full Text] [Related]
7. [Effects of losartan, ramipril and their combination on left ventricular remodeling and function in spontaneous hypertensive rats].
Xu R; Zhang Y; Zhang M; Li XC; Cai H; Chen WQ; Zhu H; Ge ZM; Zhang W
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3199-204. PubMed ID: 16405840
[TBL] [Abstract][Full Text] [Related]
8. Vascular hypertrophy and albumin permeability in a rat model combining hypertension and diabetes mellitus. Effects of calcium antagonism, angiotensin converting enzyme inhibition, and angiotensin II-AT1-receptor blockade.
Hulthén UL; Cao Z; Rumble JR; Cooper ME; Johnston CI
Am J Hypertens; 1996 Sep; 9(9):895-901. PubMed ID: 8879346
[TBL] [Abstract][Full Text] [Related]
9. Blood pressure-lowering effect of an orally active vasopressin V1 receptor antagonist in mineralocorticoid hypertension in the rat.
Burrell LM; Phillips PA; Stephenson JM; Risvanis J; Rolls KA; Johnston CI
Hypertension; 1994 Jun; 23(6 Pt 1):737-43. PubMed ID: 8206571
[TBL] [Abstract][Full Text] [Related]
10. Dual ACE and NEP inhibitor MDL-100,240 prevents and regresses severe angiotensin II-dependent hypertension partially through bradykinin type 2 receptor.
Rossi GP; Cavallin M; Rizzoni D; Bova S; Mazzocchi G; Agabiti-Rosei E; Nussdorfer GG; Pessina AC
J Hypertens; 2002 Jul; 20(7):1451-9. PubMed ID: 12131544
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects of angiotensin-converting enzyme inhibition on renal medullary neutral lipid in spontaneously hypertensive rats.
O'Sullivan JB; Harrap SB
Hypertension; 1999 May; 33(5):1214-7. PubMed ID: 10334814
[TBL] [Abstract][Full Text] [Related]
12. L-type calcium channels modulate the regression of left ventricular hypertrophy after ace-inhibition in genetic hypertension.
Vulpis V; Lograno MD; Seccia TM; Pirrelli A
Pharmacol Res; 1998 Oct; 38(4):317-22. PubMed ID: 9774496
[TBL] [Abstract][Full Text] [Related]
13. Effects of nonpeptide and selective V1 and V2 antagonists on blood pressure short-term variability in spontaneously hypertensive rats.
Japundzić-Zigon N; Milutinović S; Jovanović A
J Pharmacol Sci; 2004 May; 95(1):47-55. PubMed ID: 15153650
[TBL] [Abstract][Full Text] [Related]
14. Blood pressure responses to substances interfering with nitric oxide formation, cyclooxygenase and converting enzyme activities and vasopressin V1 receptors blockade in conscious spontaneously hypertensive and normotensive rats.
Januszewicz A; Lapiński M; Styś T; Styś A; Loń S
Pol J Pharmacol; 1994; 46(3):153-61. PubMed ID: 8000447
[TBL] [Abstract][Full Text] [Related]
15. Ramipril improves hemodynamic recovery but not microvascular response to ischemia in spontaneously hypertensive rats.
Emanueli C; Salis MB; Stacca T; Pinna A; Gaspa L; Spano A; Madeddu P
Am J Hypertens; 2002 May; 15(5):410-5. PubMed ID: 12022243
[TBL] [Abstract][Full Text] [Related]
16. Effect of vasopressin antagonism on structure and mechanics of small arteries and vascular expression of endothelin-1 in deoxycorticosterone acetate salt hypertensive rats.
Intengan HD; He G; Schiffrin EL
Hypertension; 1998 Oct; 32(4):770-7. PubMed ID: 9774378
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic, but not low-dose, angiotensin-converting enzyme inhibition causes regression of cardiovascular changes in spontaneously hypertensive rats.
Wahlander H; Sohtell M; Wickman A; Nilsson A; Friberg P
J Cardiovasc Pharmacol; 1996 Mar; 27(3):327-34. PubMed ID: 8907793
[TBL] [Abstract][Full Text] [Related]
18. AT1 receptor antagonist treatment caused persistent arterial functional changes in young spontaneously hypertensive rats.
Gillies LK; Lu M; Wang H; Lee RM
Hypertension; 1997 Dec; 30(6):1471-8. PubMed ID: 9403569
[TBL] [Abstract][Full Text] [Related]
19. Vascular and cardiac protection by ramipril in spontaneously hypertensive rats: prevention versus regression study.
Gohlke P; Linz W; Schölkens B; Van Even P; Martorana P; Unger T
Br J Clin Pract Suppl; 1996 Jul; 84():1-10. PubMed ID: 8994995
[TBL] [Abstract][Full Text] [Related]
20. Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term.
Harrap SB; Van der Merwe WM; Griffin SA; Macpherson F; Lever AF
Hypertension; 1990 Dec; 16(6):603-14. PubMed ID: 2246027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
